|
1
|
Faxon DP, Fuster V, Libby P, et al:
Atherosclerotic Vascular Disease Conference: Writing Group III:
pathophysiology. Circulation. 109:2617–2625. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dormandy J, Heeck L and Vig S: Acute limb
ischemia. Semin Vasc Surg. 12:148–153. 1999.
|
|
3
|
Costantini V and Lenti M: Treatment of
acute occlusion of peripheral arteries. Thromb Res. 106:V285–V294.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Isner JM: Therapeutic angiogenesis: a new
frontier for vascular therapy. Vasc Med. 1:79–87. 1996.PubMed/NCBI
|
|
5
|
Chen YC, Hsiao CC, Chen CJ, et al:
Toll-like receptor 2 gene polymorphisms, pulmonary tuberculosis,
and natural killer cell counts. BMC Med Genet. 11:172010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Akira S, Uematsu S and Takeuchi O:
Pathogen recognition and innate immunity. Cell. 124:783–801. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Medzhitov R, Preston-Hurlburt P and
Janeway CA Jr: A human homologue of the Drosophila Toll
protein signals activation of adaptive immunity. Nature.
388:394–397. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Carmeliet P: Angiogenesis in life, disease
and medicine. Nature. 438:932–936. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shigeoka AA, Holscher TD, King AJ, et al:
TLR2 is constitutively expressed within the kidney and participates
in ischemic renal injury through both MyD88-dependent and
-independent pathways. J Immunol. 178:6252–6258. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Leemans JC, Stokman G, Claessen N, et al:
Renal-associated TLR2 mediates ischemia/reperfusion injury in the
kidney. J Clin Invest. 115:2894–2903. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Favre J, Musette P, Douin-Echinard V, et
al: Toll-like receptors 2-deficient mice are protected against
postischemic coronary endothelial dysfunction. Arterioscler Thromb
Vasc Biol. 27:1064–1071. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mersmann J, Berkels R, Zacharowski P, et
al: Preconditioning by Toll-like receptor 2 agonist Pam3CSK4
reduces CXCL1-dependent leukocyte recruitment in murine myocardial
ischemia/ reperfusion injury. Crit Care Med. 38:903–909. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hua F, Ma J, Ha T, et al: Preconditioning
with a TLR2 specific ligand increases resistance to cerebral
ischemia/reperfusion injury. J Neuroimmunol. 199:75–82. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ha T, Lu C, Liu L, et al: TLR2 ligands
attenuate cardiac dysfunction in polymicrobial sepsis via a
phosphoinositide 3-kinase-dependent mechanism. Am J Physiol Heart
Circ Physiol. 298:H984–H991. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chang YJ, Wu MS, Lin JT and Chen CC:
Helicobacter pylori-induced invasion and angiogenesis of
gastric cells is mediated by cyclooxygenase-2 induction through
TLR2/TLR9 and promoter regulation. J Immunol. 175:8242–8252. 2005.
View Article : Google Scholar
|
|
16
|
Scholz D, Ziegelhoeffer T, Helisch A, et
al: Contribution of arteriogenesis and angiogenesis to
postocclusive hindlimb perfusion in mice. J Mol Cell Cardiol.
34:775–787. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Martin P, D’Souza D, Martin J, et al:
Wound healing in the PU.1 null mouse - tissue repair is not
dependent on inflammatory cells. Curr Biol. 13:1122–1128. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Saber T, Veale DJ, Balogh E, et al:
Toll-like receptor 2 induced angiogenesis and invasion is mediated
through the Tie2 signalling pathway in rheumatoid arthritis. PLoS
One. 6:e235402011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Muller WA, Ratti CM, McDonnell SL and Cohn
ZA: A human endothelial cell-restricted, externally disposed
plasmalemmal protein enriched in intercellular junctions. J Exp
Med. 170:399–414. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Newman PJ, Berndt MC, Gorski J, et al:
PECAM-1 (CD31) cloning and relation to adhesion molecules of the
immunoglobulin gene superfamily. Science. 247:1219–1222. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Muller WA: Leukocyte-endothelial-cell
interactions in leukocyte transmigration and the inflammatory
response. Trends Immunol. 24:327–334. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Balkwill F: Tumour necrosis factor and
cancer. Nat Rev Cancer. 9:361–371. 2009. View Article : Google Scholar
|
|
23
|
Balkwill F: TNF-alpha in promotion and
progression of cancer. Cancer Metastasis Rev. 25:409–416. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lin WW and Karin M: A cytokine-mediated
link between innate immunity, inflammation, and cancer. J Clin
Invest. 117:1175–1183. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ancrile B, Lim KH and Counter CM:
Oncogenic Ras-induced secretion of IL6 is required for
tumorigenesis. Genes Dev. 21:1714–1719. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang SP, Wu MS, Shun CT, et al:
Interleukin-6 increases vascular endothelial growth factor and
angiogenesis in gastric carcinoma. J Biomed Sci. 11:517–527. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fan Y, Ye J, Shen F, et al: Interleukin-6
stimulates circulating blood-derived endothelial progenitor cell
angiogenesis in vitro. J Cereb Blood Flow Metab. 28:90–98. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lin H, Yan J, Wang Z, et al: Loss of
immunity-supported senescence enhances susceptibility to
hepatocellular carcinogenesis and progression in TLR2-deficient
mouse. Hepatology. Aug 1–2012.(Epub ahead of print). View Article : Google Scholar
|
|
29
|
Amura CR, Renner B, Lyubchenko T, Faubel
S, Simonian PL and Thurman JM: Complement activation and Toll-like
receptor-2 signaling contribute to cytokine production after renal
ischemia/reperfusion. Mol Immunol. 52:249–257. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Correa-Costa M, Braga TT, Semedo P, et al:
Pivotal role of Toll-like receptors 2 and 4, its adaptor molecule
MyD88, and inflammasome complex in experimental tubule-interstitial
nephritis. PLoS One. 6:e290042011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xie W, Wang Y, Huang Y, Yang H, Wang J and
Hu Z: Toll-like receptor 2 mediates invasion via activating
NF-kappaB in MDA-MB-231 breast cancer cells. Biochem Biophys Res
Commun. 379:1027–1032. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shuto T, Ono T, Ohira Y, et al: Curcumin
decreases Toll-like receptor-2 gene expression and function in
human monocytes and neutrophils. Biochem Biophys Res Commun.
398:647–652. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jang JH, Yang ES, Min KJ and Kwon TK:
Inhibitory effect of butein on tumor necrosis factor-α-induced
expression of cell adhesion molecules in human lung epithelial
cells via inhibition of reactive oxygen species generation, NF-κB
activation and Akt phosphorylation. Int J Mol Med. 30:1357–1364.
2012.
|
